SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

bioAffinity Technologies, Inc.
Date: April 18, 2025 · CIK: 0001712762 · Accession: 0000000000-25-004132

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
April 18, 2025
Author
Division of
Form
UPLOAD
Company
bioAffinity Technologies, Inc.

Letter

Re: bioAffinity Technologies, Inc. Draft Registration Statement on Form S-1 Submitted April 15, 2025 CIK No. 0001712762 Dear Maria Zannes:

April 18, 2025

Maria Zannes Chief Executive Officer bioAffinity Technologies, Inc. 3300 Nacogdoches Road Suite 216 San Antonio, TX 78217

This is to advise you that we do not intend to review your registration statement.

We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Margaret Sawicki at 202-551-7153 with any questions.

Sincerely,
Division of
Corporation Finance
Office of
Industrial Applications and
Services
cc: Leslie Marlow, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 April 18, 2025

Maria Zannes
Chief Executive Officer
bioAffinity Technologies, Inc.
3300 Nacogdoches Road
Suite 216
San Antonio, TX 78217

 Re: bioAffinity Technologies, Inc.
 Draft Registration Statement on Form S-1
 Submitted April 15, 2025
 CIK No. 0001712762
Dear Maria Zannes:

 This is to advise you that we do not intend to review your registration
statement.

 We request that you publicly file your registration statement at least
two business
days prior to the requested effective date and time. Please refer to Rules 460
and 461
regarding requests for acceleration. We remind you that the company and its
management are
responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review,
comments, action or absence of action by the staff.

 Please contact Margaret Sawicki at 202-551-7153 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of
Industrial Applications and
 Services
cc: Leslie Marlow, Esq.
</TEXT>
</DOCUMENT>